Condition: Hypothyroidism · Sponsor: University of Pennsylvania
Our overall goal is to determine the clinical consequences of allowing greater flexibility in LT4 dosing in older individuals who take LT4.
This description comes directly from the study's public registry record.
Anne R. Cappola, M.D., Sc.M. · 215-573-5359 · acappola@pennmedicine.upenn.edu
Theresa M. Scattergood, M.S.N., R.N. · 215-898-9275 · theresa.scattergood@pennmedicine.upenn.edu
Always discuss trial participation with your own doctor first.
| Penn Medicine, Smilow Translational Research Center | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06073665